Effect of an ongoing pharmacist service to reduce medicine-induced deterioration and adverse reactions in aged-care facilities (nursing homes): a multicentre, randomised controlled trial (the ReMInDAR trial)

Author:

Roughead Elizabeth E1,Pratt Nicole L1,Parfitt Gaynor2,Rowett Debra1,Kalisch-Ellett Lisa M1,Bereznicki Luke3,Merlin Tracy4,Corlis Megan5,Kang Ai Choo6,Whitehouse Joseph7,Bilton Rebecca1,Schubert Camille4,Torode Stacey6,Kelly Thu-Lan1,Andrade Andre Q1ORCID,Post Dannielle2ORCID,Dorj Gereltuya1,Cousins Justin3,Williams Mackenzie3,Lim Renly1ORCID

Affiliation:

1. Quality Use of Medicines and Pharmacy Research Centre, UniSA Clinical and Health Sciences, University of South Australia, Adelaide, SA, Australia

2. Alliance for Research in Exercise, Nutrition and Activity, UniSA Allied Health & Human Performance, University of South Australia, Adelaide, SA, Australia

3. School of Medicine, University of Tasmania, Tasmania, TAS, Australia

4. Adelaide Health Technology Assessment, School of Public Health, University of Adelaide, Adelaide, SA, Australia

5. Australian Nursing and Midwifery Federation (SA Branch), Ridleyton, SA, Australia

6. University of South Australia, Adelaide, SA, Australia

7. Pharmacy Improvement Centre Ltd, Welland, SA, Australia

Abstract

Abstract Objective To assess the effectiveness of a pharmacist-led intervention using validated tools to reduce medicine-induced deterioration and adverse reactions. Design and setting Multicenter, open-label parallel randomised controlled trial involving 39 Australian aged-care facilities. Participants Residents on ≥4 medicines or ≥1 anticholinergic or sedative medicine. Intervention Pharmacist-led intervention using validated tools to detect signs and symptoms of medicine-induced deterioration which occurred every 8 weeks over 12 months. Comparator Usual care (Residential Medication Management Review) provided by accredited pharmacists. Outcomes Primary outcome was change in Frailty Index at 12 months. Secondary outcomes included changes in cognition, 24-hour movement behaviour by accelerometry, grip strength, weight, adverse events and quality of life. Results 248 persons (median age 87 years) completed the study; 120 in the interventionand, 128 in control arms. In total 575 pharmacist, sessions were undertaken in the intervention arm. There was no statistically significant difference for change in frailty between groups (mean difference: 0.009, 95% CI: −0.028, 0.009, P = 0.320). A significant difference for cognition was observed, with a mean difference of 1.36 point change at 12 months (95% CI: 0.01, 2.72, P = 0.048). Changes in 24-hour movement behaviour, grip strength, adverse events and quality of life were not significantly different between groups. Point estimates favoured the intervention arm at 12 months for frailty, 24-hour movement behaviour and grip strength. Conclusions The use of validated tools by pharmacists to detect signs of medicine-induced deterioration is a model of practice that requires further research, with promising results from this trial, particularly with regards to improved cognition.

Funder

Australian Government Department of Social Services

Publisher

Oxford University Press (OUP)

Subject

Geriatrics and Gerontology,Aging,General Medicine

Reference46 articles.

1. Advancing the responsible use of medicines: applying levers for change;Aitken;Health & the Economy eJournal,2012

2. The extent of medication-related hospital admissions in Australia: a review from 1988 to 2021;Lim;Drug Saf,2022

3. What is preventable harm in healthcare? A systematic review of definitions;Nabhan;BMC Health Serv Res,2012

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3